Literature DB >> 29437279

Radiomic features of pretreatment MRI could identify T stage in patients with rectal cancer: Preliminary findings.

Yiqun Sun1,2, Panpan Hu3, Jiazhou Wang3, Lijun Shen3, Fan Xia3, Gan Qing3, Weigang Hu3, Zhen Zhang3, Chao Xin1, Weijun Peng1, Tong Tong1, Yajia Gu1.   

Abstract

BACKGROUND: Recent studies have shown that magnetic resonance (MR) radiomic analysis is feasible and has some value in identifying tumor characteristics, but there are few data regarding the role of MR-based radiomic features in rectal cancer.
PURPOSE: The aim of this study was to determine whether radiomic features extracted from T2 -weighted imaging (T2 WI) can identify pathological features in rectal cancer. STUDY TYPE: Retrospective study. POPULATION/
SUBJECTS: A cohort comprising 119 rectal cancer patients who underwent surgery between January 2015 and November 2016. FIELD STRENGTH/SEQUENCE: 3.0T, axial high-resolution T2 -weighted turbo spin echo (TSE) sequence. ASSESSMENT: Patients were classified according to pathological features such as T stage, N stage, perineural invasion, histological grade, lymph-vascular invasion, tumor deposits, and circumferential resection margin (CRM). The whole tumor volume (WTV) was distinguished, and segments were quantified on axial high-resolution T2 WI by a radiologist. A total of 256 radiomic features were extracted. STATISTICAL TESTS: To achieve reliable results, cluster analysis and least absolute shrinkage and selection operator (LASSO) were implemented. In the cluster analysis, the patients were divided into two groups, and chi-square tests were performed to investigate the relationship between the pathological features and the radiomic-based clusters. The area under the curve (AUC) was calculated to evaluate the predictability of the model in the LASSO analysis.
RESULTS: The cluster results revealed that patients could be stratified into two groups, and the chi-square test results indicated that the pT stage was correlated with the radiomic feature cluster results (P = 0.002). The prediction model AUC for the diagnostic T stage was 0.852 (95% confidence interval: 0.677-1; sensitivity: 79.0%, specificity: 82.0%). DATA
CONCLUSION: The use of MRI-derived radiomic features to identify the T stage is feasible in rectal cancer. LEVEL OF EVIDENCE: 3 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2018.
© 2018 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  feasibility; magnetic resonance imaging; radiomics; rectal cancer

Year:  2018        PMID: 29437279     DOI: 10.1002/jmri.25969

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  23 in total

1.  MRI radiomics analysis for predicting preoperative synchronous distant metastasis in patients with rectal cancer.

Authors:  Huanhuan Liu; Caiyuan Zhang; Lijun Wang; Ran Luo; Jinning Li; Hui Zheng; Qiufeng Yin; Zhongyang Zhang; Shaofeng Duan; Xin Li; Dengbin Wang
Journal:  Eur Radiol       Date:  2018-11-09       Impact factor: 5.315

2.  Predicting the tumor response to chemoradiotherapy for rectal cancer: Model development and external validation using MRI radiomics.

Authors:  Philippe Bulens; Alice Couwenberg; Martijn Intven; Annelies Debucquoy; Vincent Vandecaveye; Eric Van Cutsem; André D'Hoore; Albert Wolthuis; Pritam Mukherjee; Olivier Gevaert; Karin Haustermans
Journal:  Radiother Oncol       Date:  2019-08-17       Impact factor: 6.280

3.  Radiomics Analysis of Fat-Saturated T2-Weighted MRI Sequences for the Prediction of Prognosis in Soft Tissue Sarcoma of the Extremities and Trunk Treated With Neoadjuvant Radiotherapy.

Authors:  Silin Chen; Ning Li; Yuan Tang; Bo Chen; Hui Fang; Shunan Qi; Ninging Lu; Yong Yang; Yongwen Song; Yueping Liu; Shulian Wang; Ye-Xiong Li; Jing Jin
Journal:  Front Oncol       Date:  2021-09-17       Impact factor: 6.244

4.  T staging with functional and radiomics parameters of computed tomography in colorectal cancer patients.

Authors:  Yafang Dou; Yingying Liu; Xiancheng Kong; Shangying Yang
Journal:  Medicine (Baltimore)       Date:  2022-05-27       Impact factor: 1.817

Review 5.  Novel imaging techniques of rectal cancer: what do radiomics and radiogenomics have to offer? A literature review.

Authors:  Natally Horvat; David D B Bates; Iva Petkovska
Journal:  Abdom Radiol (NY)       Date:  2019-11

6.  Comparison of radiomics machine-learning classifiers and feature selection for differentiation of sacral chordoma and sacral giant cell tumour based on 3D computed tomography features.

Authors:  Ping Yin; Ning Mao; Chao Zhao; Jiangfen Wu; Chao Sun; Lei Chen; Nan Hong
Journal:  Eur Radiol       Date:  2018-10-02       Impact factor: 5.315

7.  Radiomic Features of Primary Rectal Cancers on Baseline T2 -Weighted MRI Are Associated With Pathologic Complete Response to Neoadjuvant Chemoradiation: A Multisite Study.

Authors:  Jacob T Antunes; Asya Ofshteyn; Kaustav Bera; Erik Y Wang; Justin T Brady; Joseph E Willis; Kenneth A Friedman; Eric L Marderstein; Matthew F Kalady; Sharon L Stein; Andrei S Purysko; Rajmohan Paspulati; Jayakrishna Gollamudi; Anant Madabhushi; Satish E Viswanath
Journal:  J Magn Reson Imaging       Date:  2020-03-26       Impact factor: 4.813

8.  A Novel Multimodal Radiomics Model for Preoperative Prediction of Lymphovascular Invasion in Rectal Cancer.

Authors:  Yiying Zhang; Kan He; Yan Guo; Xiangchun Liu; Qi Yang; Chunyu Zhang; Yunming Xie; Shengnan Mu; Yu Guo; Yu Fu; Huimao Zhang
Journal:  Front Oncol       Date:  2020-04-07       Impact factor: 6.244

9.  MRI-based radiomics nomogram to predict synchronous liver metastasis in primary rectal cancer patients.

Authors:  Minglu Liu; Xiaolu Ma; Fu Shen; Yuwei Xia; Yan Jia; Jianping Lu
Journal:  Cancer Med       Date:  2020-05-31       Impact factor: 4.452

10.  Clinical utility of radiomics at baseline rectal MRI to predict complete response of rectal cancer after chemoradiation therapy.

Authors:  Iva Petkovska; Florent Tixier; Eduardo J Ortiz; Jennifer S Golia Pernicka; Viktoriya Paroder; David D Bates; Natally Horvat; James Fuqua; Juliana Schilsky; Marc J Gollub; Julio Garcia-Aguilar; Harini Veeraraghavan
Journal:  Abdom Radiol (NY)       Date:  2020-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.